Search Results - "Obaidi , Ammar"
-
1
The aggravating fury rituximab obliterated
Published in Haematologica (Roma) (01-06-2024)Get full text
Journal Article -
2
Assessing breast self‐examination knowledge and practices among women in Iraq: A cross‐sectional study
Published in Health science reports (01-06-2024)“…Background and Aims The present study aims to shed light on the knowledge, attitude, and practice of breast self‐examination with breast cancer (BC) among…”
Get full text
Journal Article -
3
Exceptional synergistic response of PARP inhibitor and immune checkpoint inhibitor in esophageal adenocarcinoma with a germline BRCA2 mutation: a case report
Published in Therapeutic advances in medical oncology (01-01-2024)“…Immune checkpoint inhibitors (ICIs) and poly (ADP-ribose) polymerase (PARP) inhibitors have shown efficacy in various tumors. A significant therapeutic…”
Get full text
Journal Article -
4
Spectrum of Cerebral Venous Thrombosis in Oman
Published in Sultan Qaboos University medical journal (01-08-2018)“…Objectives: Cerebral venous thrombosis (CVT) can have varied and life-threatening manifestations. This study aimed to examine the spectrum of its clinical…”
Get full text
Journal Article -
5
Ocular complications of antineoplastic therapies
Published in Future science OA (01-08-2023)“…Ocular complications of antineoplastic agents can have a profound effect on the quality of life of cancer patients. New oncologic treatments like monoclonal…”
Get full text
Journal Article -
6
SMARCB1/INI1-deficient tumors of adulthood [version 2; peer review: 2 approved]
Published in F1000 research (2020)“…The SMARCB1/INI1 gene was first discovered in the mid-1990s, and since then it has been revealed that loss of function mutations in this gene result in…”
Get full text
Journal Article -
7
532 A cross-cohort examination of factors impacting immunotherapy survival in non-small cell lung cancer (NSCLC)
Published in Journal for immunotherapy of cancer (01-11-2023)“…BackgroundHighly variable responses to immune checkpoint inhibitors (ICI) among NSCLC patients underscore the need for predictive biomarkers to guide therapy…”
Get full text
Journal Article -
8
Inflammatory Myofibroblastic Tumor of the Lung: An Extremely Rare Condition in Adults
Published in Curēus (Palo Alto, CA) (20-12-2019)“…Inflammatory myofibroblastic tumors (IMTs) of the lung were first reported in 1939. The most common site of predilection is the lungs of the pediatric…”
Get full text
Journal Article -
9
Nivolumab versus the standard of care for cancer therapy: A meta-analysis of 6 CHECKMATE trials comparing overall survival
Published in Journal of clinical oncology (20-05-2020)“…Abstract only e15165 Background: Nivolumab (N) is an antineoplastic agent approved for multiple different tumor origins as well as tumor agnostic based on MSI…”
Get full text
Journal Article -
10
Pembrolizumab versus the standard of care for cancer therapy: A meta-analysis of 12 KEYNOTE trials comparing overall survival
Published in Journal of clinical oncology (20-05-2019)“…Abstract only e14159 Background: Pembrolizumab (P) is an antineoplastic agent approved for multiple different tumor origins as well as tumor agnostic based on…”
Get full text
Journal Article -
11
Advancements and future trends of immunotherapy in light-chain amyloidosis
Published in Critical reviews in oncology/hematology (01-03-2023)“…Light-chain (AL) amyloidosis is a type of plasma cell neoplasm with abnormal monoclonal immunoglobulin light-chain production and their subsequent deposition…”
Get full text
Journal Article -
12
Pre-operative Carboplatin/Paclitaxel Versus 5-Fluorouracil (5-FU)-based Chemoradiotherapy for Older Adults With Esophageal Cancer
Published in Anticancer research (01-01-2022)“…This study aimed to compare the efficacy and tolerability of pre-operative platinum/5-fluorouracil (P5F) and carboplatin/paclitaxel (CP), in combination with…”
Get full text
Journal Article -
13
A Novel EGFR Germline Mutation in Lung Adenocarcinoma: Case Report and Literature Review
Published in Clinical lung cancer (01-07-2024)“…•While most molecular testing focuses on somatic alterations in patients with non-small cell lung cancer, evidence is growing regarding the presence of…”
Get full text
Journal Article -
14
Visual Hallucinations With Arsenic Trioxide Therapy in Acute Promyelocytic Leukemia
Published in Curēus (Palo Alto, CA) (12-08-2024)“…A 68-year-old male with a history of diabetes and hypertension was diagnosed with acute promyelocytic leukemia (APML). He underwent induction therapy with…”
Get full text
Journal Article -
15
Ehrlichia-Induced Hemophagocytic Lymphohistiocytosis (HLH) With No Response to Doxycycline Treatment
Published in Curēus (Palo Alto, CA) (23-07-2023)“…Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening condition characterized by the persistent activation of antigen-presenting cells and…”
Get full text
Journal Article -
16
A Challenging Case of Kaposi Sarcoma Inflammatory Cytokine Syndrome
Published in Curēus (Palo Alto, CA) (20-07-2023)“…Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS) is a serious, uncommon disease that occurs in patients who are positive for HIV and human herpesvirus-8…”
Get full text
Journal Article -
17
Obstructive Jaundice Secondary to Extramedullary Hematopoiesis
Published in Curēus (Palo Alto, CA) (13-09-2021)“…Extramedullary hematopoiesis (EMH) is the development of hematopoietic tissue outside of the bone marrow. In adults, the bone marrow is the main site of…”
Get full text
Journal Article -
18
An extremely rare case of presacral ganglioneuroma in a young male with lower back pain: First case report from Iraq
Published in Radiology case reports (01-12-2024)“…Lower back pain with radiculopathy is a common clinical presentation caused by several conditions, some of which are rare pathologies that could have been…”
Get full text
Journal Article -
19
Spontaneous, Loculated, and Massive Hemothorax: An Uncommon Complication of Warfarin Therapy
Published in Curēus (Palo Alto, CA) (09-05-2021)“…Warfarin, a commonly used oral anticoagulant, is associated with several adverse drug reactions, principally bleeding. Of all hemorrhagic complications from…”
Get full text
Journal Article -
20
SMARCB1/INI1-deficient tumors of adulthood [version 1; peer review: 1 approved]
Published in F1000 research (2020)“…The SMARCB1/INI1 gene was first discovered in the mid-1990's, and since then it has been revealed that loss of function mutations in this gene result in…”
Get full text
Journal Article